Free Trial
NASDAQ:MASS

908 Devices Q1 2025 Earnings Report

908 Devices logo
$5.60 +0.24 (+4.48%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$5.47 -0.13 (-2.32%)
As of 05:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

908 Devices EPS Results

Actual EPS
N/A
Consensus EPS
-$0.29
Beat/Miss
N/A
One Year Ago EPS
N/A

908 Devices Revenue Results

Actual Revenue
N/A
Expected Revenue
$11.90 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

908 Devices Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

908 Devices Earnings Headlines

URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
Leerink Partners Remains a Hold on 908 Devices (MASS)
908 Devices reports preliminary Q1 revenue $11.5M. consensus $11.9M
See More 908 Devices Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 908 Devices? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 908 Devices and other key companies, straight to your email.

About 908 Devices

908 Devices (NASDAQ:MASS), a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

View 908 Devices Profile

More Earnings Resources from MarketBeat